4//SEC Filing
Sullivan Christopher Ryan 4
Accession 0001470831-25-000409
CIK 0001534120other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 4:17 PM ET
Size
4.8 KB
Accession
0001470831-25-000409
Insider Transaction Report
Form 4
Sullivan Christopher Ryan
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2025-12-10$4.10/sh−155$636→ 17,338 total
Footnotes (1)
- [F1]Includes 417 additional shares acquired pursuant to the Issuer's Employee Stock Purchase Plan as a part of this reporting transaction.
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
Related Parties
1- filerCIK 0001810417
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 4:17 PM ET
- Size
- 4.8 KB